NCT00111956View on ClinicalTrials.gov

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Metabolic Syndrome X
Interventions
DRUG

Etanercept

DRUG

Placebo

Trial Locations (1)

02114

Mass General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00111956 - Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter